High Dose Magnesium Sulfate Exposure Induces Apoptotic Cell Death in the Developing Neonatal Mouse Brain
- 10 February 2009
- journal article
- research article
- Published by S. Karger AG in Neonatology
- Vol. 96 (1) , 23-32
Abstract
Background: Magnesium sulfate (MgSO4) is often used as a treatment for pre-eclampsia/eclampsia and preterm labor, resulting in the exposure of a significant number of neonates to this drug despite a lack of evidence suggesting that it is safe, or effective as a tocolytic. While there is evidence that MgSO4 may be neuroprotective in perinatal brain injury, recent reviews have suggested that the effects are dependent upon dose, and that higher doses may actually increase neonatal morbidity and mortality. There is a lack of evidence investigating the neurotoxic effects of neonatal magnesium (Mg) exposure on the developing brain, specifically in terms of neurodevelopmental apoptosis, a cell-killing phenomenon known to be potentiated by other drugs with mechanisms of action at Mg-binding sites (i.e. NMDA receptor antagonists such as MK-801, ketamine, and PCP). Objective: To investigate the effects of Mg exposure on the neonatal mouse brain at different postnatal ages to determine whether MgSO4 treatment causes significant cell death in the developing mouse brain. Methods: C57Bl/6 mice were treated with four doses of MgSO4 (250 mg/kg) on postnatal days 3 (P3), 7 (P7) or 14 (P14). Caspase-3 immunohistochemistry, cupric silver staining, and electron microscopy techniques were used to examine Mg-treated brains for neurotoxic effects. Results: Qualitative evaluation using cupric silver staining revealed widespread damage throughout the brain in P7 animals. Results of electron microscopy confirmed that the cell death process was apoptotic in nature. Quantitative evaluation of damage to the cortex, caudate-putamen, hippocampus, thalamus, and cerebellum showed that Mg treatment caused significant brain damage in animals treated on P3 and P7, but not P14. Conclusions: Administration of high doses of Mg may be detrimental to the fetal brain, particularly if exposure occurs during critical periods of neurodevelopment.Keywords
This publication has 54 references indexed in Scilit:
- Magnesium Sulfate Compared With Nifedipine for Acute Tocolysis of Preterm LaborObstetrics & Gynecology, 2007
- Magnesium sulphate given before very‐preterm birth to protect infant brain: the randomised controlled PREMAG trial*BJOG: An International Journal of Obstetrics & Gynaecology, 2006
- Magnesium Sulfate TocolysisObstetrics & Gynecology, 2006
- Effect of magnesium sulfate on contractile force and intracellular calcium concentration in pregnant human myometriumAmerican Journal of Obstetrics and Gynecology, 2006
- Neurodevelopmental outcome of infants with birth asphyxia treated with magnesium sulfatePediatrics International, 2006
- Stroke and Severe Preeclampsia and Eclampsia: A Paradigm Shift Focusing on Systolic Blood PressureObstetrics & Gynecology, 2005
- Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administrationBehavioural Brain Research, 2004
- Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhageObstetrics & Gynecology, 1999
- Effect of Magnesium Sulfate on the Development of Cystic Periventricular Leukomalacia in Preterm InfantsAmerican Journal of Perinatology, 1997
- Neonatal stroke: Clinical characteristics and cerebral blood flow velocity measurementsPediatric Neurology, 1994